General practitioners (GPs) and nurse practitioners will be able to start medical treatment for adults with ADHD, following decisions by Medsafe and Pharmac.

Who is eligible To be eligible for transitional access, patients must either: be receiving private treatment with the cancer medicine at the time Pharmac begins its public funding; or start treatment ...

The Director for Radiation Safety (the Director) intends to review the Code of Practice for Sealed Radioactive Material: ORS C12 2020 (ORS C12 2020). The review will be conducted in accordance with ...

Starting from 1 July 2025, when a cancer medicine starts to be funded by Pharmac, patients in private facilities will be able to continue their treatment with publicly funded medicines in the same ...

Background Under section 53 of the Residential Care and Disability Support Services Act 2018, the Director-General of Health has determined the maximum contribution that applies in each region for ...

This rest home has been audited against the Health and Disability Services Standards. During the last audit, the auditors identified some areas for improvement. Issues from their last audit are listed ...

As a department of the public service, the Ministry of Health – Manatū Hauora has a responsibility to contribute to the Crown meeting its obligations under Te Tiriti o Waitangi. This statement ...

The Annual Data Explorer presents results from the 2022/23 New Zealand Health Survey, with comparisons to earlier surveys where possible. Results are available by gender, age group, ethnic group, ...

Trends in daily smoking and daily vaping vary by ethnic group Daily smoking has declined in all ethnic groups from 2011/12 to 2023/24, although trends have been more variable in Asian and Pacific ...

Our climate is changing. These changes are affecting what we value most in our lives, including our health and wellbeing. This first Health National Adaptation Plan (HNAP) is an important step towards ...

This position statement accompanies the release of an evidence brief which examines the safety and long-term impacts of puberty blockers when used in the context of gender-affirming care. This ...